The aim of this study was to investigate the chemical composition and provide a pharmacological base for the medicinal use of the essential oil of Perovskia abrotanoides (Pa.Oil) in gastrointestinal disorders, such as colic. The chemical investigation resulted in the identification of 26 compounds, of which tricyclene, -trans-ocimene, terpinene-4-acetate, terpinen-4-ol, caran-3-ol, linalyl acetate, -caryophyllene oxide and -elemene had not previously been reported from P. abrotanoides. Major constituents were 1,8-cineol and -3-carene, which constituting 50% of the oil. In the isolated rabbit jejunum preparation Pa.Oil caused inhibition of spontaneous and high K + (80 mM)-induced contractions, with respective EC 50 values of 0.13 (0.08-0.20; n=4) and 0.90 mg/mL (0.50-1.60; n=5), thus showing that spasmolytic activity is mediated possibly through calcium channel blockade (CCB). The CCB activity was confirmed when pre-treatment of the tissue with Pa.Oil (0.03-0.1 mg/mL) caused a rightward shift in the Ca ++ concentration-response curves, similar to that caused by verapamil, a standard calcium channel blocker. These data indicate that the essential oil of P. abrotanoides possesses spasmolytic activity mediated possibly through inhibition of voltage-dependent calcium channels, which may explain its medicinal use in colic and possibly diarrhea.
This study is a continuation of our investigations of the chemical and biological activity of essential oils from Pakistan [1, 2] . Perovskia abrotanoides Karel, (Syn. P. artemisioides Boiss), locally known as "Shanshohai", belongs to the family Lamiaceae (order Lamiales). It is native to South and Northwest regions of Pakistan, growing in mountainous regions, at 2200 to 4200 m elevation. The people of South and Central Asia knew it very well since very old times for its antibacterial, antileishmanial, antacid, and cooling activities. The essential oil is normally extracted from aerial parts of the flowering plant of P. abrotanoides [3, 4] .
The constituents of the essential oil include mainly monoterpenes and sesquiterpenes (in a ratio of ~ 4:1). 1,8-Cineol, myrcene, -pinene, camphor, -caryophyllene, -humulene, camphene, -bisabolol, and various other constituents have been reported [5, 6] . A report stating a high content of methylcitronellate, nerol, limonene, and p-cymene is also available [7] . Very little literature is available on the pharmacological activities of P. abrotanoides except for a few studies on its antibacterial, leishmanicidal, antiplasmodial, and cytotoxic activities [8] .
Essential oil from P. abrotanoides (Pa. oil) found in Pakistan has not been explored for its biological activity related to its medicinal use in hyperactive gut disorders. The current study reports on the chemistry of the essential oil of the aerial parts of this plant and the pharmacological mechanism(s) involved in its use in hyperactive gut disorders, such as colic and possibly diarrhea.
Pa. oil was subjected to GC-FID and GC-EIMS analysis. Twentysix compounds were identified, mainly from their mass spectra [9] , comprising 99.2% of the essential oil. Identifications were further supported with retention indices (RI) cited in the literature ( Table  1 ). Comparison of the 13 C NMR spectra of the mixture with those recorded for the pure authentic compounds further helped in the identification [10] . The chemical shift values obtained for the compounds in the oil were in good agreement with those reported [11, 12] . This study has resulted in the identification of eight components new from this source, including tricyclene (1), -transocimene (8), terpinene-4-acetate (9), terpinen-4-ol (13), carane-3ol (14) , linalyl acetate (15), -caryophyllene oxide (24) , and -elemene (26) . The main constituents were 1,8-cineol (7) and -3-carene (6), which constituting 50% of the oil.
In line with the medicinal reputation of P. abrotanoides in hyperactive gut disorders, such as colic and diarrhea [17] , Pa. oil was tested in isolated gut preparations. In the isolated rabbit jejunum preparation, cumulative addition of Pa.Oil inhibited thecontraction, with an EC 50 value of 0.13 mg/mL (0.08-0.20; n=4), as shown in Figure 1A *Current (from GC-FID responses) and ** Previously reported, RI; Retention Indices on HP-5 ® , n.r.; Not reported previously for P. abrotanoides. *** Also supported with 13 C NMR spectra [10, 11, 12] .
The contraction of smooth muscle preparations, including rabbit jejunum, is dependent upon an increase in the intracellular free [Ca ++ ], which activates the contractile elements [18] . The increase in intracellular Ca ++ occurs either via influx through voltagedependant Ca ++ channels (VDCs) or its release from intracellular stores in the sarcoplasmic reticulum. Periodic depolarization and repolarization regulates the spontaneous rhythmic movements of the intestine and, at the height of depolarization, the action potential appears as a rapid influx of Ca ++ via VCDs [19] . The inhibitory effect of the essential oil on spontaneous rhythmic contractions of rabbit jejunum may be due to interference either with the Ca ++ release or with the Ca ++ influx through VDCs.
We previously observed that the spasmolytic constituents present in different medicinal plants mediate their spasmolytic effect, usually through a CCB [20, 21, 22] . To see whether the spasmolytic effect of the Pa. oil is mediated through CCB, a high concentration of K + (80 mM) was used to induce depolarization. The essential oil was then added in a cumulative fashion, where it caused relaxation of the induced contraction with an EC 50 value of 0.90 mg/mL (0.50-1.60; n=5), suggesting a CCB effect ( Figure 1A) . Verapamil, a standard calcium channel blocker [23] , also inhibited the spontaneous and high K + -induced contractions, as expected ( Figure 1C ).
The contractions induced by high K + (> 30 mM) are dependent on the entry of Ca ++ into the cells through VDCs [24] and a substance which can inhibit high K + -induced contractions is, therefore, considered to be a possible CCB [25] . Thus, the inhibition of high K + (80 mM)-induced contraction of rabbit jejunum by the Pa. oil may reflect the interference of Ca ++ entry through VDCs. This hypothesis was further strengthened when pretreatment of the tissues with the essential oil (0.03-0.1 mg/mL) caused a rightward shift in the Ca ++ CRCs (Figure 1B ), similar to that caused by verapamil ( Figure 1D ), a standard calcium channel blocker [23] .
These data indicate that the essential oil of P. abrotanoides possesses calcium channel blocking activity, which may provide indirect evidence for its medicinal use in hyperactive gut disorders, such as, colic and possibly diarrhea, as the CCBs are known to be useful in these conditions [26] .
In summary, this investigation reports, for the first time, the identification of 26 compounds, eight of which are new records, from the essential oil of P. abrotanoides (Pa. oil) from Pakistan and the presence of antispasmodic activity, mediated possibly through blockade of voltage-dependent calcium channels, which provides a pharmacological basis for its medicinal use in colic and possibly diarrhea.
Experimental
Essential oil: Fresh, authentic samples of P. abrotanoides Karel., from three different locations of Quetta district, Pakistan, were collected in September 2009. An identified voucher specimen (PA.RBT.10) has been deposited in the herbarium of the Department of Botany, University of Baluchistan, Quetta, Pakistan. Plant material was subjected to hydro-distillation [27] . The essential oil (Pa. Oil) was obtained as a clear thin oil with a yellowish tint.
The oils, diluted with Et 2 O, were analyzed by GC-FID. Since there was no remarkable difference in these chromatograms, all 3 samples were pooled (approx. 10 mL; 0.15% yield) and 1 to 5 L was subjected to GC analyses. Pharmacological activities of Perovskia abrotanoides essential oil Natural Product Communications Vol. 8 (11) 2013 1635 Instrumentation and identification: Gas chromatography using FID, was carried out on a Shimadzu gas chromatograph GC-17A linked to Shimadzu Class GC-10 software, and equipped with a SPB-5 ® column (30 m x 0.53 mm ID x 0.50 m film thickness of 5% phenyl-95% methyl silicone). The analyses were performed with an initial temperature 50°C for 5 min, and then ramped at 3°C/min to a final temperature 210°C with final time of 45 min. Injector, with a splitting ratio of 1:50, and FID were set at 300°C. Carrier and make up gas was nitrogen with a flow of 28 and 40 mL/min at a pressure of 1.0 and 2.5 kg/cm 2 , respectively. Retention indices were also calculated [28] .
For GC-EIMS experiments a Hewlett-Packard 5890 gas chromatograph was combined with a Jeol, JMS-HX 110 mass spectrometer operating in EI mode with the ion source at 270°C and electron energy at 70 eV. Injector was set at 250°C with a splitting ratio of 1:30. Analyses were performed using the aforementioned program on an equivalent HP-5 ® column (25 m  0.22 mm and 0.25 m film thickness). Mass spectral survey was performed using a MS-library [9] . The concentrations were calculated using the area normalization method by GC-FID. 13 C NMR (BB and DEPT) spectra of the essential oil were recorded in CDCl 3 on a Bruker Aspect AM-300 spectrometer operating at 75 MHz.
Drugs and standards:
Acetylcholine chloride, potassium chloride, and verapamil were obtained from the Sigma Chemical Company, St. Louis, MO, USA. All chemicals used were of the highest purity grade, their stock solutions were made in distilled water, and the dilutions were made fresh in normal saline on the day of experiment.
Animals: Experiments performed complied with the rulings of the Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council [29] . Local rabbits (1.5-2 kg) of either sex used in the study were bred and housed in the animal house of Aga Khan University under controlled environmental conditions (23-25 °C) .
Isolated tissue preparations -Rabbit jejunum:
The isolated tissue experiments were carried out as previously described [1] . The animals had free access to water, but were fasted for 24 h before the experiment. The animals were sacrificed by cervical dislocation, the abdomen was cut open and the jejunal portion isolated. Preparations 2-3 cm long were mounted in 10 mL tissue baths containing normal Tyrode's solution maintained at 37°C and aerated with a mixture of 5% carbon dioxide in oxygen (carbogen). The composition of Tyrode's solution, in mM, was: NaCl 136.9, KCl 2.7, MgCl 2 1.1, NaHCO 3 11.9, NaH 2 PO 4 0.4, glucose 5.6, and CaCl 2 1.8 (pH 7.4). A preload of 1 g was applied and the tissues kept undisturbed for an equilibrium period of 30 min after which control responses to a submaximal concentration of acetylcholine (ACh; 0.3 M) were obtained and the tissue presumed stable only after the reproducibility of the said responses. Isotonic responses were recorded on a Bioscience transducer and oscillograph. Under these experimental conditions, rabbit jejunum exhibits spontaneous rhythmic contractions, allowing testing of the relaxant (spasmolytic) activity directly without the use of an agonist [20] .
Determination of calcium channel blocking activity:
To assess whether the spasmolytic activity of the test substances was mediated through calcium channel blockade (CCB), high K + (80 mM), as KCl, was used to depolarize the preparations [30] . K + was added to the tissue bath, which produced a sustained contraction. The Pa. oil was then added in a cumulative fashion to obtain inhibitory response curves, which is expressed as percent of the control response produced by high K + . Substances which produce relaxation against high K + -induced contractions may act through the antagonism of Ca ++ movements, possibly through voltagedependent calcium channels [24] .
To confirm the calcium channel blocking (CCB) activity of the test substances, the tissues were allowed to stabilize in normal Tyrode's solution, which was then replaced with Ca ++ free Tyrode's solution containing EDTA (0.1 mM) for 30 min in order to remove calcium from the tissues. This solution was further replaced with K + -rich and Ca ++ -free Tyrode's solution, having the following composition: NaCl 91.04, KCl 50.00, MgCl 2 1.05, NaHCO 3 11.90, NaH 2 PO 4 0.42, glucose 5.6, and EDTA 0.1 mM. Following an incubation period of 30 min, control concentration response curves (CRCs) of Ca ++ were obtained. When the control CRCs of Ca ++ were found superimposable (usually after 2 cycles), the tissue was pretreated with the test substance for 1 h to test the possible CCB effect. The CRCs of Ca ++ were reconstructed in the presence of different concentrations of the test material.
Statistics:
All data expressed are mean + standard error mean (SEM, n=number of experiments) and the median effective concentration (EC 50 values) with 95% confidence intervals (CI). The statistical parameter applied was the Student's t-test (paired or unpaired) with P < 0.05 as significantly different (GraphPAD program, GraphPAD, San Diego, CA, USA); concentration response curves were analyzed by non-linear regression.
